INSIGHTS ON DRUG DEVELOPMENT

• Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights

  Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

• Overcoming Volume And Viscosity Barriers In Biologic Formulations

  Learn how advanced containment solutions support high-viscosity biologics, improve device compatibility, enhance injection performance, and address evolving drug delivery and patient care challenges.

• Facilitate Handling Of Bulk Powders With Dry Granulation

  Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.

• Bridging The Gap Between Traditional Models And Human Biology

  Whether you are new to Organ-on-a-Chip technology or seeking to expand your expertise, watch to gain the knowledge and insights needed to effectively implement this technology into your research.

• Navigating The Analytical Complexity Of Oligonucleotide Therapeutics

  9/13/2024

  From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.

• NanoImprove The Performance Of Your Formulations

  9/24/2024

  Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

• Managing Endotoxins - Detect, Prevent, Remove

  9/8/2025

  Explore the risks of endotoxin contamination in drug manufacturing and discover sustainable, animal-free detection methods to ensure pharmaceutical safety and regulatory compliance.

• An Alternative Method Of Drug-Excipient Characterization

  12/30/2024

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances

  5/6/2026

  Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.